Clinical Development Clinical Research Nurses 
XTalks
JUNE 4, 2024
Oren Cohen, MD, FIDSA CMO & President of Clinical Pharmacology Fortrea Fortrea is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, market access solutions and other enabling services. They are unique and require specific expertise.” FIH studies involve a lot of risk.
XTalks
OCTOBER 18, 2022
A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. Read on to learn why life science and clinical research professionals are choosing a career with Medpace.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ACRP blog
DECEMBER 28, 2022
From AI and machine learning producing an era of rapid new pathways, to an industry-wide push for equitable representation in clinical trials, 2023 will be a catalytic year for biopharma clinical development and commercialization,” the company notes in its press release on this, its 13th annual trends report.
pharmaphorum
JANUARY 19, 2021
What does this mean for clinical trials in the future? The COVID-19 pandemic has turned many aspects of clinical research upside down; however it will also be a powerful agent for change in the way the pharma industry conducts clinical trials.
pharmaphorum
DECEMBER 23, 2022
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Side effects and cost implications. Professional reception of the findings.
pharmaphorum
OCTOBER 10, 2022
Once an eligible patient registers their interest in the service, a specially trained respiratory nurse will conduct an initial phone assessment. If the patient is deemed at high risk of developing lung cancer, they are offered a low dose CT scan to further investigate their lung health.
XTalks
NOVEMBER 19, 2021
Liz Moore, DNP, advanced clinical nurse practitioner at Medpace, says that until the future of cardiac biomarkers arrives, CV clinical trials will have to continue to include and learn from the current markers. Full-Service Clinical Development. Mitigating Risk and the Patient Experience.
Expert insights. Personalized for you.
110 
Let's personalize your content